High PD‐L1 expression may be a predictor of the incidence of AEs associated with treatment responsiveness, considering the mechanisms of AE occurrence, such as shared cancer antigens, potential autoimmune disease, and cytokine activity. The gene discussed is CD274; the disease is cancer.